| Quarterly Financials | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 268 | 206 | 411 | 361 | 363 | 478 | 417 | 398 | 388 | 501 | 588 | 569 | 581 | 609 | 655 | 609 | 638 | 693 | 782 | 790 | 812 | 879 | 965 | 1,003 | 1,087 |
| Expenses | 203 | 165 | 268 | 268 | 258 | 330 | 283 | 264 | 259 | 358 | 412 | 411 | 413 | 449 | 475 | 459 | 475 | 509 | 559 | 585 | 599 | 679 | 757 | 799 | 879 |
| EBITDA | 65 | 40 | 143 | 93 | 105 | 148 | 134 | 134 | 129 | 143 | 177 | 158 | 168 | 160 | 180 | 150 | 163 | 184 | 223 | 205 | 213 | 200 | 208 | 204 | 208 |
| Operating Profit % | 24 % | 18 % | 34 % | 26 % | 28 % | 30 % | 31 % | 33 % | 31 % | 28 % | 27 % | 27 % | 28 % | 26 % | 27 % | 24 % | 25 % | 26 % | 28 % | 24 % | 25 % | 22 % | 21 % | 20 % | 18 % |
| Depreciation | 17 | 17 | 16 | 20 | 17 | 17 | 18 | 19 | 19 | 29 | 31 | 33 | 35 | 32 | 33 | 35 | 46 | 39 | 41 | 45 | 53 | 53 | 66 | 79 | 85 |
| Interest | 10 | 9 | 7 | 9 | 7 | 6 | 3 | 3 | 4 | 6 | 8 | 12 | 5 | 9 | 9 | 12 | 16 | 18 | 20 | 26 | 27 | 33 | 45 | 57 | 68 |
| Profit Before Tax | 38 | 14 | 120 | 65 | 81 | 125 | 113 | 112 | 107 | 107 | 138 | 113 | 127 | 119 | 139 | 102 | 100 | 127 | 162 | 135 | 134 | 114 | 97 | 69 | 55 |
| Tax | 10 | 5 | 29 | 17 | 22 | 33 | 29 | 28 | 24 | 28 | 31 | 31 | 29 | 32 | 37 | 26 | 29 | 32 | 42 | 42 | 28 | 29 | 25 | 17 | 22 |
| Net Profit | 28 | 9 | 90 | 48 | 59 | 92 | 84 | 84 | 83 | 79 | 106 | 82 | 99 | 87 | 101 | 77 | 72 | 95 | 121 | 93 | 106 | 85 | 72 | 52 | 33 |
| EPS in ₹ | 3.72 | 1.49 | 11.21 | 6.55 | 7.72 | 11.48 | 10.34 | 10.14 | 10.08 | 8.74 | 12.14 | 9.49 | 11.65 | 10.10 | 11.50 | 8.98 | 8.18 | 10.82 | 2.68 | 2.22 | 2.54 | 1.96 | 1.67 | 1.33 | 1.06 |
Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences
824.25
-26.40
(-3.10%)
Market Cap
34,619.03 Cr
PE Ratio
147.70
Volume
3,14,020.00
Day High - Low
858.00 - 818.10
52W High-Low
855.80 - 575.80
Key Fundamentals
Market Cap
34,619.03 Cr
EPS
6.03
PE Ratio
147.70
PB Ratio
9.54
Book Value
89.22
EBITDA
790.80
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
17.15
Debt to Equity
0.99
Analyst Rating and Forecast
- By Refinitiv from13 analysts
Actual
Company News
View All News
Krishna Institute of Medical Sciences: ₹57.31 Cr Block TradeJun 22, 2026
Krishna Institute of Medical Sciences sees a block trade of ~7,09,779 shares worth ₹57.31 crores on NSE at ₹807.40 per share.
KIMS opens QIP issue at ₹771.73 floor price
Jun 16, 2026
Jun 16, 2026Krishna Institute of Medical Sciences opened a Qualified Institutions Placement with a floor price of ₹771.73 per share. The issue aims to raise capital following shareholder approval.
Krishna Institute files FY26 audited resultsJun 16, 2026
Jun 16, 2026Krishna Institute of Medical Sciences Ltd filed audited standalone and consolidated financial statements for FY26. Statutory auditors confirmed adequate internal financial controls.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,888.50 | #1 1,27,802.99 | 63.88 | #1 25,228.50 | 14.70 | #1 2,032 | 33.00 | 75.36 | |
1,132.50 | 1,10,219.86 | 77.81 | 8,373.45 | 16.56 | 1,464 | 7.27 | 69.74 | |
980.05 | 73,989.67 | 69.13 | 9,127.84 | 16.28 | 1,064 | 44.26 | 55.32 | |
791.55 | 41,011.87 | 96.20 | 4,643.22 | 8.32 | 384 | #1 79.65 | 57.38 | |
1,999.10 | 40,853.77 | 50.76 | 7,896.04 | #1 41.63 | 788 | 13.53 | 61.64 | |
1,351.10 | 36,326.73 | 65.48 | 4,410.27 | 16.94 | 584 | 39.64 | 73.33 | |
824.25 | #7 34,619.03 | #10 147.70 | #7 3,904.60 | #2 27.31 | #9 198 | #10 -68.80 | 70.03 | |
481.20 | 15,253.22 | 90.50 | 2,080.08 | 18.39 | 168 | 17.65 | 58.48 | |
1,441.60 | 14,640.77 | 51.93 | 1,703.08 | 8.69 | 262 | 38.41 | 62.99 | |
287.80 | 12,430.97 | #1 46.49 | 1,679.36 | 17.77 | 272 | 46.56 | 60.11 |
Growth Rate
Revenue Growth
27.31 %
Net Income Growth
-52.34 %
Cash Flow Change
11.65 %
ROE
6.85 %
ROCE
-11.21 %
EBITDA Margin (Avg.)
-24.35 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 958 | 1,118 | 1,196 | 1,436 | 1,907 | 2,941 | 3,852 | 5,736 | 7,759 |
| Fixed Assets | 755 | 863 | 916 | 931 | 1,005 | 1,766 | 2,434 | 3,349 | 5,978 |
| Current Assets | 156 | 174 | 220 | 451 | 393 | 478 | 547 | 697 | 937 |
| Capital Work in Progress | 0 | 0 | 2 | 9 | 21 | 477 | 600 | 1,214 | 606 |
| Investments | 0 | 0 | 0 | 0 | 333 | 68 | 157 | 99 | 97 |
| Other Assets | 203 | 254 | 278 | 496 | 549 | 630 | 660 | 1,075 | 0 |
| Total Equity & Liabilities | 958 | 1,118 | 1,196 | 1,436 | 1,907 | 2,941 | 3,852 | 5,736 | 7,759 |
| Current Liabilities | 749 | 201 | 219 | 278 | 215 | 297 | 452 | 836 | 1,239 |
| Non Current Liabilities | 347 | 351 | 366 | 282 | 282 | 707 | 1,307 | 2,481 | 3,961 |
| Total Equity | -138 | 566 | 611 | 876 | 1,411 | 1,938 | 2,093 | 2,419 | 2,247 |
| Reserve & Surplus | -209 | 466 | 523 | 786 | 1,307 | 1,590 | 1,748 | 2,058 | 2,167 |
| Share Capital | 50 | 75 | 75 | 78 | 80 | 80 | 80 | 80 | 80 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 5 | -11 | 5 | 3 | -3 | 33 | 12 | -27 | 36 | -15 | 9 |
| Investing Activities | -71 | -41 | -100 | -64 | -110 | -125 | -354 | -412 | -416 | -753 | -1,116 |
| Operating Activities | 64 | 95 | 82 | 106 | 134 | 202 | 356 | 324 | 432 | 521 | 582 |
| Financing Activities | 12 | -66 | 24 | -39 | -27 | -44 | 10 | 61 | 20 | 217 | 543 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.84 % | 38.82 % | 38.82 % | 38.82 % | 38.82 % | 38.82 % | 38.82 % | 34.11 % | 34.11 % | 34.11 % | 34.11 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 8.61 % | 8.61 % | 0.00 % | 14.25 % | 0.00 % | 16.73 % | 17.84 % | 15.85 % | 15.68 % | 15.45 % | 15.54 % | 15.03 % | 14.33 % | 14.57 % |
| DIIs | 13.81 % | 16.11 % | 18.35 % | 18.49 % | 20.46 % | 27.98 % | 28.32 % | 29.76 % | 33.03 % | 34.80 % | 31.63 % | 33.13 % | 32.12 % | 32.30 % | 32.05 % | 31.95 % | 31.66 % | 32.12 % | 32.71 % | 32.50 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 13.14 % | 14.23 % | 13.38 % | 12.88 % | 11.81 % | 11.50 % | 11.32 % | 11.10 % | 11.22 % | 11.15 % | 10.84 % | 10.73 % | 10.61 % | 10.55 % | 10.97 % | 11.24 % | 11.58 % | 11.72 % | 11.76 % | 11.84 % |
| Others | 34.21 % | 30.82 % | 29.42 % | 29.79 % | 28.88 % | 21.68 % | 12.92 % | 11.69 % | 16.91 % | 0.96 % | 18.70 % | 0.59 % | 0.61 % | 2.48 % | 2.48 % | 2.54 % | 7.11 % | 7.03 % | 7.09 % | 6.98 % |
| No of Share Holders | 0 | 267 | 86,389 | 74,355 | 73,664 | 70,795 | 67,735 | 60,980 | 65,449 | 66,957 | 71,014 | 69,092 | 69,063 | 77,617 | 95,468 | 1,01,895 | 1,08,955 | 1,04,872 | 1,01,599 | 93,333 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 27 Aug 2026 |  Annual General Meeting | NA | 27 Aug 2026 | 761.60 | 850.65 |
| 09 Jul 2026 |  Extraordinary General Meeting | NA | 09 Jul 2026 | 785.10 | 850.65 |
| 29 Aug 2024 | Annual General Meeting | NA | 29 Aug 2024 | 389.93 | 502.38 |
| 28 Jun 2024 |  Split | 2:10 | 13 Sept 2024 | 420.62 | 420.62 |
| 09 Nov 2024 |  Quarterly Result Announcement | NA | 09 Nov 2024 | 520.35 | 570.15 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 606.05 | 649.15 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 657.35 | 635.00 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 763.85 | 741.05 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 635.00 | 737.40 |
| 07 Nov 2025 | Quarterly Result Announcement | NA | 07 Nov 2025 | 720.20 | 720.15 |
| 06 Feb 2026 | Quarterly Result Announcement | NA | 06 Feb 2026 | 593.55 | 606.45 |
| 15 May 2026 | Quarterly Result Announcement | NA | 15 May 2026 | 675.95 | 773.30 |
Announcements
Corrigendum To Notice Of The Extraordinary General Meeting Of The Company Scheduled To Be Held Of 9 July 20261 day ago
1 day agoClosure of Trading WindowJun 25, 2026
Jun 25, 2026Intimation Of Approval.Jun 23, 2026
Jun 23, 2026Announcement under Regulation 30 (LODR)-Qualified Institutional PlacementJun 19, 2026
Jun 19, 2026Announcement under Regulation 30 (LODR)-Qualified Institutional PlacementJun 19, 2026
Jun 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 18, 2026
Jun 18, 2026Extraordinary General Meeting (EGM) Of The Members Of The Company Will Be Held On Thursday 9 July 2026 At 04:00 P.M. (IST) Through Video Conferencing/ Other Audio Visual Means (VC/ OAVM).Jun 17, 2026
Jun 17, 2026Extraordinary General Meeting (EGM) Of The Members Of The Company Will Be Held On Thursday 9 July 2026 At 04:00 P.MJun 17, 2026
Jun 17, 2026The Finance & Investment Committee Has At Its Meeting Held Today
I.E. 16Th June 2026 Inter-Alia Considered And Approved The Following:
(A) Approval And Adoption Of The Preliminary Placement Document Dated 16Th June 2026 Together With The
Application FoJun 16, 2026
Jun 16, 2026Audited Standalone And Consolidated Financial Statements For The Financial Year Ended 31St March 2026.Jun 16, 2026
Jun 16, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E 13.06.2026Jun 13, 2026
Jun 13, 2026Board Meeting Intimation for Fund RaisingJun 10, 2026
Jun 10, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 05, 2026
Jun 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 02, 2026
Jun 02, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 01, 2026
Jun 01, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 22, 2026
May 22, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 16, 2026
May 16, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 16, 2026
May 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2026
May 16, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2026
May 15, 2026ResultsMay 15, 2026
May 15, 2026Board Meeting Outcome for OutcomeMay 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2026
May 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2026
May 12, 2026Intimation Of Entering Into A Long-Term Lease Agreement For 2 Acres Of Land For A Period Of 60 Years In Amaravati Andhra Pradesh.May 08, 2026
May 08, 2026Board Meeting Intimation for Board Meeting Intimation.May 06, 2026
May 06, 2026Intimation Of Entering Into Memorandum Of Understanding For Strategic Clinical CollaborationApr 23, 2026
Apr 23, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 17, 2026
Apr 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
Apr 13, 2026Pursuant To Provisions Of Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 KIMS Swastha Private Limited (The KIMS) A Wholly-Owned Subsidiary Of Krishna Institute Of Medical ScieApr 02, 2026
Apr 02, 2026The Subsidiary Company Has Received An Order Under Section 143(3) Read With Sections 250 And 144B Of The Income-Tax Act In Which The Department Has Set Aside The Said Demand Notice And Accordingly The Amount Payable In Respect Of This Matter Is Rs.0/- (ZeMar 31, 2026
Mar 31, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 17, 2026
Mar 17, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 14, 2026
Mar 14, 2026Board Meeting Outcome for Outcome Of Board MeetingMar 11, 2026
Mar 11, 2026Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On 11Th March 2026.Mar 06, 2026
Mar 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2026
Feb 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Feb 09, 2026General UpdateFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-AcquisitionFeb 06, 2026
Feb 06, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 70.03
ATR(14)
Less Volatile 24.12
STOCH(9,6)
Neutral 76.84
STOCH RSI(14)
Overbought 100.00
MACD(12,26)
Bullish 3.32
ADX(14)
Strong Trend 40.53
UO(9)
Bearish 50.52
ROC(12)
Uptrend And Accelerating 9.25
WillR(14)
Overbought -5.59
About Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences Limited (KIMS) is an Indian healthcare company operating 12 multispecialty hospitals under the KIMS Hospitals brand. With over 4,000 beds, KIMS provides tertiary and quaternary healthcare services across more than 40 specialties and super specialties. The company's network includes hospitals in Telangana, Andhra Pradesh, and...more
Listing Date
28 Jun, 2021(5 Years,
-22 days)
Chairperson NameBhaskara Rao Bollineni
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
